Measuring and Predicting Glycemic Response to Food in Patients With Type 1 Diabetes
NCT02919839 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-09-29
Summary
Personalized medicine methods in the management of type 1 diabetes
Conditions
- Personalized Medicine in Type 1 Diabetes
Interventions
- OTHER
-
non-Interventional
Sponsors & Collaborators
-
Weizmann Institute of Science
collaborator OTHER -
Dr. Orit Hamiel
lead OTHER_GOV
Principal Investigators
-
Orit Hamiel, Prof · Sheba Medical Center
-
Eran Segal, Prof. · Weizmann Institute of Science
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2018-09-30
- Completion
- 2019-01-31
More Related Trials
-
Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients
NCT01978704 ·Status: COMPLETED ·Phase: NA
-
Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes
NCT02068638 ·Status: COMPLETED ·Phase: NA
-
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
NCT01693302 ·Status: COMPLETED ·Phase: NA
-
GIP and GLP-1 in Type 1 Diabetes
NCT01739283 ·Status: COMPLETED ·Phase: NA
-
Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes
NCT01930097 ·Status: COMPLETED ·Phase: PHASE2
-
GPR119 Agonist for Hypoglycemia in Type 1 Diabetes
NCT04432090 ·Status: COMPLETED ·Phase: PHASE2
-
Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients
NCT01525784 ·Status: UNKNOWN
-
Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
NCT00891995 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
NCT03490942 ·Status: TERMINATED ·Phase: PHASE2
-
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
NCT02660242 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in New Onset Type 1 Diabetes
NCT00279305 ·Status: COMPLETED ·Phase: PHASE2
-
MDRS for Prevention of Nocturnal Hypoglycemia
NCT01509157 ·Status: COMPLETED ·Phase: PHASE1
-
Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes
NCT06683391 ·Status: RECRUITING ·Phase: NA
-
Closed-loop Glucose Control for Automated Management of Type 1 Diabetes
NCT00811317 ·Status: COMPLETED ·Phase: NA
-
Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
NCT04014569 ·Status: TERMINATED ·Phase: NA
-
Tissue-Specific Metabolic Reprogramming in Diabetic Complications
NCT01823406 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
NCT01919385 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of a Moderate Carbohydrate Diet in Children With Type 1 Diabetes on Hybrid Closed-loop Therapy
NCT06567158 ·Status: RECRUITING ·Phase: NA
-
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
NCT04031599 ·Status: COMPLETED ·Phase: NA
-
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
NCT03349489 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp
NCT03581968 ·Status: COMPLETED ·Phase: NA
-
Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus
NCT04439903 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus
NCT06097689 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus
NCT01418703 ·Status: COMPLETED ·Phase: NA
-
Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes
NCT00595569 ·Status: COMPLETED